D-penicillamine induced pemphigus treated with methylprednisolone pulse therapy. 1990

E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
Immunologie en Rheumatologie, Universitair Ziekenhuis Antwerpen, Edegem.

A patient with severe rheumatoid arthritis received d-penicillamine treatment for 16 months. She developed mild pruritus 6 months after d-penicillamine initiation, and severe pemphigus 10 months after d-penicillamine was changed to azathioprine. Subsequent methylprednisolone pulse therapy resulted in a transient clinical remission of pemphigus. A literature review of d-penicillamine induced pemphigus and high dose methylprednisolone pulse therapy is presented.

UI MeSH Term Description Entries
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
January 1983, Duodecim; laaketieteellinen aikakauskirja,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
July 2004, The Journal of dermatological treatment,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
January 1980, Dermatologica,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
March 1982, Journal of the American Academy of Dermatology,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
August 1975, British medical journal,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
November 1978, Die Medizinische Welt,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
January 2007, Archives of Iranian medicine,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
July 1980, Zeitschrift fur Hautkrankheiten,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
February 1999, Annales de dermatologie et de venereologie,
E A Wouters, and L S De Clerck, and L Francx, and W J Stevens
July 1976, The British journal of dermatology,
Copied contents to your clipboard!